Home>
US Stocks>
Capricor Therapeutics

Capricor Therapeutics share price today

(CAPR)

Capricor Therapeutics share price is $13.07 & ₹1,110.64 as on 21 Dec 2024, 2.30 'hrs' IST

$13.07

▲

0.17

(1.32%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Capricor Therapeutics share price in Dollar and Rupees. Guide to invest in Capricor Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Capricor Therapeutics. Get details on the Indian mutual funds that are investing in Capricor Therapeutics. Get Analyst recommendations and forecasts along with all the Capricor Therapeutics's financials.

Capricor Therapeutics share price movements

Today's Low: $12.60
Today's High: $13.50
$13.07
3.6%
Downside
Day's Volatility :6.67%
Upside
3.19%
52 Weeks Low: $3.52
52 Weeks High: $23.40
$13.07
73.07%
Downside
52 Weeks Volatility :84.96%
Upside
44.15%

Capricor Therapeutics Returns

Period	Capricor Therapeutics Inc	Index (Russel 2000)
3 Months	118.93%	0.0%
6 Months	172.86%	0.0%
1 Year	193.71%	0.0%
3 Years	300.92%	-19.7%

Capricor Therapeutics Key Statistics

in dollars & INR

Previous Close	$12.9
Open	$12.64
Today's High	$13.5
Today's Low	$12.6
Market Capitalization	$586.6M
Today's Volume	$5.5M
52 Week High	$23.4
52 Week Low	$3.52
Revenue TTM	$23.2M
EBITDA	$-34.8M
Earnings Per Share (EPS)	$-1.02
Profit Margin	-146.86%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-392.69%

How to invest in Capricor Therapeutics from India?

It is very easy for Indian residents to invest directly in Capricor Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Capricor Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Capricor Therapeutics or CAPR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Capricor Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Capricor Therapeutics shares which would translate to 0.065 fractional shares of Capricor Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Capricor Therapeutics, in just a few clicks!

Returns in Capricor Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Capricor Therapeutics investment value today

Current value as on today

₹2,95,904

Returns

₹1,95,904

(+195.9%)

Returns from Capricor Therapeutics Stock

₹1,93,708 (+193.71%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Capricor Therapeutics

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Capricor Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 3% more investors are searching Capricor Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Capricor Therapeutics

BlackRock Inc
3.58%
Vanguard Group Inc
3.47%
Geode Capital Management, LLC
1.40%
State Street Corp
1.13%
SUPERSTRING CAPITAL MANAGEMENT LP
0.74%
Ikarian Capital, LLC
0.66%

Analyst Recommendation on Capricor Therapeutics

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Capricor Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Capricor Therapeutics

What analysts predicted

Upside of 215.88%

Current:

$13.07

Target:

$41.29

Insights on Capricor Therapeutics

Price Movement
In the last 1 month, CAPR stock has moved down by -26.5%
Decreasing Revenue
Revenue is down for the last 4 quarters, 12.08M → 2.26M (in $), with an average decrease of 40.5% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, -762.08K → -12.55M (in $), with an average decrease of 403.9% per quarter

Capricor Therapeutics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.7M	↑ 22.25%
Net Income	$-15.2M	↓ 724.78%
Net Profit Margin	-908.91%	↓ 1086.75%

	FY19	Y/Y Change
Revenue	$1.0M	↓ 39.87%
Net Income	$-7.4M	↓ 51.43%
Net Profit Margin	-734.09%	↑ 174.82%

	FY20	Y/Y Change
Revenue	$310.3K	↓ 69.13%
Net Income	$-13.5M	↑ 82.71%
Net Profit Margin	-4.3K%	↓ 3610.86%

	FY21	Y/Y Change
Revenue	$244.9K	↓ 21.06%
Net Income	$-19.4M	↑ 43.98%
Net Profit Margin	-7.9K%	↓ 3580.43%

	FY22	Y/Y Change
Revenue	$2.5M	↑ 940.81%
Net Income	$-29.0M	↑ 49.51%
Net Profit Margin	-1.1K%	↑ 6786.9%

	FY23	Y/Y Change
Revenue	$25.2M	↑ 887.79%
Net Income	$-22.3M	↓ 23.2%
Net Profit Margin	-88.52%	↑ 1049.96%

	Q2 FY23	Q/Q Change
Revenue	$3.9M	↑ 31.16%
Net Income	$-7.4M	↓ 101.8%
Net Profit Margin	-188.04%	↓ 13871.18%

	Q3 FY23	Q/Q Change
Revenue	$6.2M	↑ 57.9%
Net Income	$-6.4M	↓ 13.25%
Net Profit Margin	-103.31%	↑ 84.73%

	Q4 FY23	Q/Q Change
Revenue	$12.1M	↑ 95.42%
Net Income	$-762.1K	↓ 88.07%
Net Profit Margin	-6.3%	↑ 97.01%

	Q1 FY24	Q/Q Change
Revenue	$4.9M	↓ 59.41%
Net Income	$-9.8M	↑ 1185.16%
Net Profit Margin	-199.6%	↓ 193.3%

	Q2 FY24	Q/Q Change
Revenue	$4.0M	↓ 19.06%
Net Income	$-11.0M	↑ 12.31%
Net Profit Margin	-276.97%	↓ 77.37%

	Q3 FY24	Q/Q Change
Revenue	$2.3M	↓ 43.05%
Net Income	$-12.6M	↑ 14.15%
Net Profit Margin	-555.2%	↓ 278.23%

	FY18	Y/Y Change
Profit	$1.7M	↑ 22.25%

	FY19	Y/Y Change
Profit	$-4.1M	↓ 347.51%

	FY20	Y/Y Change
Profit	$-8.1M	↑ 96.93%

	FY21	Y/Y Change
Profit	$-799.0	↓ 99.99%

	FY22	Y/Y Change
Profit	$1.9M	↓ 232145.81%

	FY23	Y/Y Change
Profit	$24.1M	↑ 1200.36%

	Q2 FY23	Q/Q Change
Profit	$3.7M	↓ 178.49%

	Q3 FY23	Q/Q Change
Profit	$5.9M	↑ 61.05%

	Q4 FY23	Q/Q Change
Profit	$11.8M	↑ 99.35%

	Q1 FY24	Q/Q Change
Profit	$4.6M	↓ 61.16%

	Q2 FY24	Q/Q Change
Profit	$3.6M	↓ 21.0%

	Q3 FY24	Q/Q Change
Profit	$2.3M	↓ 37.43%

	FY18	Y/Y Change
Operating Cash Flow	$-13.9M	↓ 2.59%
Investing Cash Flow	$4.7M	↓ 6.22%
Financing Cash Flow	$6.9M	↓ 40.82%

	FY19	Y/Y Change
Operating Cash Flow	$-6.8M	↓ 50.79%
Investing Cash Flow	$-3.0M	↓ 164.26%
Financing Cash Flow	$9.2M	↑ 33.91%

	FY20	Y/Y Change
Operating Cash Flow	$-10.1M	↑ 47.4%
Investing Cash Flow	$5.4M	↓ 281.18%
Financing Cash Flow	$33.4M	↑ 263.73%

	FY21	Y/Y Change
Operating Cash Flow	$-16.8M	↑ 67.18%
Investing Cash Flow	$-1.2M	↓ 121.99%
Financing Cash Flow	$20.2M	↓ 39.41%

	FY22	Y/Y Change
Operating Cash Flow	$4.9M	↓ 129.25%
Investing Cash Flow	$-35.1M	↑ 2831.78%
Financing Cash Flow	$4.9M	↓ 75.9%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-9.4M	↓ 323.69%
Investing Cash Flow	$6.5M	↓ 301.18%
Financing Cash Flow	$2.2M	↑ 56076.48%

Capricor Therapeutics Technicals Summary

Sell

Neutral

Buy

Capricor Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Capricor Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Capricor Therapeutics Inc	-26.53%	172.86%	193.71%	300.92%	1038.8%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.11%	13.66%	87.56%
Biontech Se	4.48%	30.56%	7.36%	-56.46%	225.6%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.49%	30.99%	109.19%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-1.97%	78.33%	80.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Capricor Therapeutics Inc	NA	NA	0.0	-1.0	-3.93	-0.44	NA	0.73
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Capricor Therapeutics Inc	Buy	$586.6M	1038.8%	NA	-146.86%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	87.56%	17.51	33.61%
Biontech Se	Buy	$26.7B	225.6%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	109.19%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.59%	32.84	-4.51%

About Capricor Therapeutics

capricor therapeutics, inc. (nasdaq: capr) is a clinical-stage biotechnology company focused on the discovery, development, and commercialization of first-in-class biological therapeutics for the treatment of rare disorders. our innovative technology builds upon a large body of scientific research and enables us to approach the treatment of diseases in novel ways. capricor’s lead candidate, cap-1002, is an “off-the-shelf” cardiac cell therapy that is currently in clinical development for the treatment of duchenne muscular dystrophy (dmd). cap-1002 consists of allogeneic cardiosphere-derived cells, or cdcs, a unique population of cells which include progenitor cells that have been shown to exert potent immunomodulatory activity, which alters the immune system’s activity to stimulate cellular regeneration. cdcs have been the subject of over 100 peer-reviewed scientific publications and have been administered to approximately 140 human subjects across several clinical trials. capricor has

Organization	Capricor Therapeutics
Employees	101
CEO	Dr. Frank Isaac Litvack FACC, M.D.
Industry	Health Technology

Management People of Capricor Therapeutics

Name	Title
Dr. Frank Isaac Litvack FACC, M.D.	Executive Chairman of the Board
Dr. Linda Marbán Ph.D.	Co-Founder, President, CEO & Director
Mr. Anthony J. Bergmann M.B.A.	CFO & Corporate Treasurer
Ms. Karen G. Krasney	Executive VP, General Counsel & Secretary
Dr. Kristi A. H. Elliott Ph.D.	Chief Science Officer
Catherine Lee Kelleher	Consultant

Important FAQs about investing in Capricor Therapeutics from India :

What is Capricor Therapeutics share price today?

Capricor Therapeutics share price today stands at $13.07, Open: $12.64 ; Previous Close: $12.90 ; High: $13.50 ; Low: $12.60 ; 52 Week High: $23.40 ; 52 Week Low: $3.52. The stock opens at $12.64, after a previous close of $12.90. The stock reached a daily high of $13.50 and a low of $12.60, with a 52-week high of $23.40 and a 52-week low of $3.52.

Can Indians buy Capricor Therapeutics shares?

Yes, Indians can invest in the Capricor Therapeutics (CAPR) from India.

With INDmoney, you can buy Capricor Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Capricor Therapeutics at zero transaction cost.

How can I buy Capricor Therapeutics shares from India?

It is very easy to buy Capricor Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Capricor Therapeutics be purchased?

Yes, you can buy fractional shares of Capricor Therapeutics with INDmoney app.

What are the documents required to start investing in Capricor Therapeutics stocks?

To start investing in Capricor Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.